Ventricular function and tissue characterization by cardiac magnetic resonance imaging following hospitalization for

Michael P DiLorenzo1, Kanwal M Farooqi2, Amee M Shah2

  • 1Department of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA. Mpd2001@cumc.columbia.edu.

Pediatric Radiology
|October 18, 2022
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) appears to have minimal long-term myocardial impact, with most children showing no residual heart damage six to nine months post-infection. Further research is needed to understand the full long-term implications of MIS-C on pediatric cardiac health.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Cardiovascular Imaging

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infection.
  • MIS-C often presents with acute cardiac dysfunction and cardiogenic shock.
  • Long-term myocardial effects of MIS-C are not well understood.

Purpose of the Study:

  • To evaluate residual myocardial disease in children 6-9 months after MIS-C hospitalization.
  • To compare cardiac MRI findings in MIS-C survivors with healthy controls.
  • To assess long-term cardiac health in pediatric MIS-C patients.

Main Methods:

  • Prospective cardiac MRI performed on 13 children 6-9 months post-MIS-C hospitalization.
  • Comparison of native T1 and T2 mapping values with 20 healthy controls.
  • Inclusion of children with and without prior cardiac abnormalities during MIS-C hospitalization.

Main Results:

  • Most children (12/13) had normal left and right ventricle ejection fractions.
  • Normal extracellular volume (ECV), T2, and native T1 times were observed in most patients.
  • One child showed late gadolinium enhancement (LGE) despite normal ejection fraction and myocardial mapping values.

Conclusions:

  • Residual myocardial damage appears minimal 6-9 months after MIS-C.
  • Cardiac MRI findings suggest limited long-term myocardial impact in most pediatric MIS-C survivors.
  • Further studies are warranted to fully elucidate the long-term cardiovascular implications of MIS-C.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
132
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
22
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19